PEM Currents: The Pediatric Emergency Medicine Podcast

Brad Sobolewski, MD, MEd

PEM Currents: The Pediatric Emergency Medicine Podcast is an evidence-based podcast focused on the care of ill and injured children in the Emergency Department. The host is Brad Sobolewski, MD, MEd author of PEMBlog.com and a Professor of Pediatric Emergency Medicine at Cincinnati Children’s and the University of Cincinnati.

  1. 3d ago

    Toxicology: Bupropion

    Bupropion is a commonly prescribed antidepressant, but overdose can lead to seizures, cardiac conduction abnormalities, and even cardiogenic shock. In this episode of PEM Currents, pediatric emergency medicine physicians Dr. Xavier Idriss and Dr. Becca Spegele discuss the clinical presentation, pharmacology, and management of bupropion toxicity in children and adolescents. Learn why seizures can be delayed for up to 24 hours, how to manage neurologic and cardiovascular complications, and what determines observation, admission, and disposition.   Learning Objectives After listening to this episode, learners should be able to: Recognize the clinical manifestations of bupropion toxicity, including early neurologic warning signs, delayed seizures, and cardiovascular complications. Describe the acute management of bupropion overdose, including benzodiazepine administration, gastrointestinal decontamination, cardiac monitoring, and supportive care. Determine appropriate observation periods and disposition based on bupropion formulation, clinical presentation, and severity of toxicity. References Cincinnati Drug and Poison Information Center. Bupropion toxicity. Published 2024. Accessed October 2026. Rianprakaisang T, Blumenberg A, Hendrickson RG. Characteristics and frequency of bupropion overdose with a delayed seizure. J Med Toxicol. 2021;17(1):45-52. DOI not provided. Starr P, Klein-Schwartz W, Spiller H, Kern P, Ekleberry SE, Kunkel S. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009;27(8):911-915. doi:10.1016/j.ajem.2008.07.004 Offerman S, Gosen J, Thomas SH, Padilla-Jones A, Ruha AM, Levine M. Bupropion associated seizures following acute overdose: who develops late seizures. Clin Toxicol (Phila). 2020;58(12):1306-1312. DOI not provided. Beuhler MC, Spiller HA, Sasser HC. The outcome of unintentional pediatric bupropion ingestions: a NPDS database review. J Med Toxicol. 2010;6(1):4-8. doi:10.1007/s13181-010-0034-2 Script The following is the original edited episode script, with minor grammatical corrections. Why Bupropion Is So Dangerous Today we’re talking about bupropion, also called Wellbutrin, Zyban, or Aplenzin. Bupropion is a unicyclic antidepressant, and structurally it’s actually a cousin of amphetamines. It’s commonly prescribed, both for depression and for smoking cessation, which also means it’s readily available in households where young children may accidentally ingest it or adolescents may take it intentionally. Bupropion has such a narrow seizure margin that it was actually pulled from the market in 1986 after seizures were reported at daily doses of 400 to 600 milligrams. It returned three years later with lower recommended doses, but seizures can still occur, even at therapeutic doses and in patients without a seizure history. And in overdose, toxicity can be delayed, particularly with sustained- and extended-release formulations. That delay is important, and we’ll come back to it throughout this episode. How Kids Present So what does this kid look like when they arrive in your ED? Think about three organ systems: the brain, the heart, and the gut. But understand that the brain is where the real trouble lives. Let’s start with the CNS. Tremors and seizures are the effects you’re most worried about. With immediate-release formulations, seizures typically occur within the first few hours. But with sustained- and extended-release products, seizures can be delayed for up to 24 hours after ingestion. In fact, seizures have been reported in approximately one-third of bupropion overdose cases. Classically, these are one or two brief generalized tonic-clonic seizures that resolve on their own, but recurrent seizures and status epilepticus can occur. Some patients have a prodrome before seizing, typically consisting of agitation, tremors, and hallucinations. If you see that triad, consider it a warning shot. You may also see paresthesias, lightheadedness, lethargy, and confusion. Moving to the cardiovascular system, sinus tachycardia is common, and you may see some hypertension. QRS widening, QT prolongation, and other conduction abnormalities are less common but can occur with more severe toxicity. Cardiogenic shock has also been reported. It’s uncommon, but it completely changes how you resuscitate, so keep it in the back of your mind if the patient becomes hypotensive. And the gut? Nausea and vomiting. That’s about it. Putting it all together, the typical patient is tachycardic, agitated, maybe tremulous, and the thing you’re really watching and waiting for is a seizure. Pharmacology Pearls Let’s talk through the pertinent pharmacology. Here’s the take-home pearl of this section: delayed and prolonged toxicity are common. Bupropion’s time to peak is roughly two hours for immediate-release, three hours for sustained-release, and five hours for extended-release formulations. And its active metabolites peak even later, around six hours after ingestion. The half-life of bupropion ranges from four to twenty-four hours at therapeutic doses, while its active metabolites can stick around even longer, with half-lives ranging from nine to forty-three hours. That prolonged exposure, particularly with sustained- and extended-release formulations, helps explain why our observation windows are so long. Bupropion inhibits dopamine and norepinephrine reuptake, and the resulting CNS stimulation is thought to contribute to its seizure risk. Two more quick notes. First, bupropion isn’t effectively removed by hemodialysis because of its large volume of distribution and high protein binding, so don’t count on dialysis to help in an overdose. Second, when you see QRS widening, it’s primarily due to impaired cardiac gap-junction communication rather than sodium-channel blockade. That’s an important distinction because it means sodium bicarbonate may not work the way it does for other toxic ingestions. Management and Observation Alright, so what do you actually do when caring for a patient with bupropion toxicity? First, before anything else: supportive care. Airway, breathing, circulation. Stabilize the patient first. Then the fundamentals: cardiac monitor, IV or IO access, a glucose check, and an ECG. On that ECG, you’re hunting for tachycardia, QRS widening, and QT prolongation. And keep in mind there’s no routine blood or urine assay for bupropion, so this is primarily a clinical, history-driven diagnosis. Now let’s walk through the specific problems. For seizures and significant agitation, your answer is IV benzodiazepines. They can also help with the associated hypertension and tachycardia, although those findings don’t necessarily require treatment on their own. For hypotension, consider a bedside echo. This is where that rare cardiogenic shock can come back to bite you. Assessing cardiac function can help guide your fluid resuscitation and choice of vasoactive medications, particularly if the patient isn’t responding as expected. For QRS widening, sodium bicarbonate is reasonable to try, especially if you’re concerned about a possible co-ingestion. However, as we mentioned earlier, bupropion’s effects on cardiac conduction aren’t primarily due to sodium-channel blockade, so bicarbonate may not be effective. In severe cases with refractory cardiovascular collapse, intravenous lipid emulsion and even VA-ECMO have been used as rescue therapies. These are uncommon situations where you’ll want toxicology and critical care involved early. Now, decontamination. Consider activated charcoal for a potentially toxic ingestion, particularly if the patient presents early and can safely receive it. Although charcoal is most effective early, it may still be useful several hours after ingestion, especially with large ingestions or sustained- and extended-release formulations. Whole bowel irrigation may also be worth considering for selected large modified-release ingestions. These are decisions to make with Poison Control and Medical Toxicology, especially given the risk of sudden seizures and aspiration. Finally, observation. For potentially toxic immediate-release ingestions, a minimum of twelve hours of observation is a reasonable approach. Sustained- and extended-release ingestions generally require admission and monitoring for twenty-four hours because of the risk of delayed seizures. The exact duration should be individualized based on the dose, formulation, symptoms, and Poison Control recommendations. Disposition So who goes home, and who stays? Home: An asymptomatic child after a confirmed immediate-release ingestion can potentially go home, but only after completing the recommended observation period without symptoms, typically at least twelve hours for a potentially toxic ingestion, and always in coordination with Poison Control. Remember, every intentional ingestion needs a psychiatric evaluation before that patient is discharged, whether that be from the emergency department or inpatient setting. Admit: Patients with potentially toxic sustained- or extended-release ingestions generally warrant admission and monitoring for twenty-four hours. The delayed seizures are just too unpredictable to gamble on. Even with immediate-release products, patients who develop symptoms may require admission. ICU: Anyone with recurrent seizures, status epilepticus, hemodynamic instability, cardiogenic shock, or significant conduction abnormalities. Three Take-Homes Let’s close with three things to carry out of here. Number one: bupropion is a seizure-causing drug first. Watch for agitation, tremors, and hallucinations as warning signs, and remember that benzodiazepines are your first-line treatment for seizures. Number two: respect the delayed clock. Potentially toxic immediate-release ingestions generally warrant at least twelve hours of observation. Sustained- and extended-rel

  2. Nov 4

    Minor Procedures: Hair-Thread Tourniquet Syndrome

    Hair-thread tourniquet syndrome can progress from swelling and pain to ischemia and significant tissue injury if the constricting fiber is not completely released. In this episode of PEM Currents: The Pediatric Emergency Medicine Podcast, we review a stepwise approach to hair-thread tourniquet release, including chemical depilation, mechanical removal, and incisional release. We also discuss anesthesia, assessment of reperfusion, wound care, antibiotic use, and when to involve a surgical specialist. Learning Objectives After listening to this episode, you should be able to: Recognize hair-thread tourniquet syndrome, including cases in which the constricting hair or thread is deeply embedded or no longer visible. Select an appropriate release technique based on the constricting material, integrity of the skin, depth of the tourniquet, and degree of tissue injury. Describe chemical, mechanical, and incisional techniques for complete release of a hair-thread tourniquet. Select appropriate anesthesia and post-procedure care, including assessment of reperfusion, wound care, indications for antibiotics, and situations requiring surgical consultation. References Alruwaili N, Alshehri HA, Halimeh B. Hair tourniquet syndrome: Successful management with a painless technique. International Journal of Pediatrics and Adolescent Medicine. 2015;2:34-37. Arkoubi AY, Salati SA. Hair-Thread Tourniquet Syndrome: A Comprehensive Review. Cureus. 2024;16(5):e60832. doi:10.7759/cureus.60832. Barton DJ, Sloan GM, Nichter LS, Reinisch JF. Hair-thread tourniquet syndrome. Pediatrics. 1988;82(6):925-928. Bean JF, Hebal F, Hunter CJ. A single center retrospective review of hair tourniquet syndrome and a proposed treatment algorithm. J Pediatr Surg. 2015. Claudet I, Pasian N, Maréchal C, Salanne S, Debuisson C, Grouteau E. Hair-thread tourniquet syndrome. Arch Pediatr. 2010;17:474-479. Gottlieb M, Holladay D, Spearman D. Current approach to the evaluation and management of hair-thread tourniquets. Pediatr Emerg Care. 2019. Kudzinskas A, Reed A, Mahdi M, Tyler M. Evaluation of depilatory agents in the treatment of hair-thread tourniquet syndrome. J Emerg Med. 2021. Loiselle JM, Cronan K. Hair Tourniquet Removal. In: Henretig FM, King C, eds. Textbook of Pediatric Emergency Procedures. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:1065-1068. Martonovich N, Khatib M, Assaf M. Hair tourniquet syndrome: A retrospective study. Pediatr Dermatol.2023;40(1):125-128. doi:10.1111/pde.15151. O’Gorman A, Ratnapalan S. Hair tourniquet management. Pediatr Emerg Care. 2011;27(3):203-204. Prabhakar H, Rath S, Kalaivani M, Bhanderi N. Adrenaline with lidocaine for digital nerve blocks. Cochrane Database Syst Rev. 2015;(3):CD010645. Peckler B, Hsu CK. Tourniquet syndrome: a review of constricting band removal. J Emerg Med. 2001;20(3):253-262. Strahlman RS. Toe tourniquet syndrome in association with maternal hair loss. Pediatrics. 2003;111(3):169-170. Wiltrakis SM, Jaggi P, Lu L, Jain S. Optimizing antibiotic treatment of skin infections in pediatric emergency and urgent care centers. Pediatrics. 2022. Additional Resource Cheetham A. Management of Hair-Thread Tourniquet Syndrome. PEMBlog. September 1, 2026. The article includes a treatment algorithm, procedural techniques, and illustrations of hair-thread tourniquet release. ⁠Read the PEMBlog article Transcript This transcript was generated using Descript and subsequently reviewed and lightly edited for spelling, grammar, and clarity. Minor inaccuracies may remain, and the audio recording should be considered the definitive version of this content. Welcome to PEM Currents, the Pediatric Emergency Medicine Podcast. As always, I’m your host, Brad Sobolewski, and today we’re going to talk about hair-thread tourniquet syndrome. This is an uncommon problem, but one where recognizing it quickly and completely releasing the constriction can prevent significant tissue injury. Hair-thread tourniquet syndrome occurs when a strand of hair, thread, or another thin fiber becomes tightly wrapped around an appendage. Toes are the most commonly affected site overall, but fingers and genitalia, including the penis, clitoris, and labia, can also be involved. Human hair is the most common constricting material, but synthetic fibers, thread, and even thin elastic bands have all been described. Management of Hair-Thread Tourniquet Syndrome – PEMBlog.pdf The pathophysiology is a progressive cycle. The constricting band first impairs lymphatic and venous outflow. The appendage becomes edematous, which makes the band even tighter and causes it to become more deeply embedded. Eventually arterial blood flow can become compromised, resulting in ischemia, tissue necrosis, and potentially loss of the appendage. And if the process has been going on for a while, granulation tissue or re-epithelialization can actually grow over the constricting fiber, making it even harder to identify. Management of Hair-Thread Tourniquet Syndrome – PEMBlog.pdf So prompt and complete release of that constricting fiber is the mainstay of treatment. Fortunately, despite how concerning some of these can look, most can be managed without an operation. In the largest single-center series, about 94% were managed nonoperatively. Let’s start with recognition and assessment. Classically, you’re looking for a circumferential groove with distal edema, erythema, pain, and sometimes cyanosis. But the hair or thread itself may not be obvious. It can be incredibly fine, buried within edematous tissue, or completely covered by granulation tissue or new epithelium. So if you have an edematous toe or finger with a circumferential groove, the fact that you can’t see a hair doesn’t rule out a tourniquet. Take a close look at the entire circumference of the appendage with good lighting and magnification. Assess distal perfusion, including color and capillary refill, and look at the degree of soft-tissue injury. On a finger, assess motor and sensory function when possible. You also want to determine, as best you can, whether you’re dealing with actual hair or synthetic thread, because that becomes important when deciding how you’re going to release it. The treatment approach is stepwise and depends on the depth and visibility of the constricting fiber, the condition of the skin, the degree of tissue injury, and whether the constrictor is hair or thread. Management of Hair-Thread Tourniquet Syndrome – PEMBlog.pdf For an appropriate hair tourniquet, a chemical depilatory is a great place to start. This is painless, noninvasive, and successful in roughly two-thirds of cases after one or two treatment cycles. Over-the-counter depilatory creams contain thioglycolate, which disrupts the chemical bonds in hair keratin. Apply the cream directly over the area of constriction and allow it to sit for about three to ten minutes. Then completely remove the cream, wash the area thoroughly with water, and reassess. You may need forceps to remove residual pieces because the hair frequently breaks apart rather than coming off as one intact strand. Management of Hair-Thread Tourniquet Syndrome – PEMBlog.pdf There are some important limitations. Depilatory cream only works on hair. It does nothing to cotton, rayon, polyester, or other synthetic fibers. You also shouldn’t use it on mucosal surfaces or over broken or ulcerated skin, and obviously avoid it in a patient with a known allergy to the product. So chemical depilation is not the universal first step for every hair-thread tourniquet. It’s an excellent first option when you’re dealing with hair and the skin is intact. If the constricting fiber is superficial enough that you can grasp it, if you’re dealing with synthetic thread, or if depilation fails, move to mechanical release. The simplest technique is to identify the free end with fine forceps or a hemostat and gently unwind the fiber. If you can see the constrictor but can’t easily unwind it, carefully pass a blunt probe or metal ear curette underneath it, usually approaching from the dorsal surface. Once you know the probe is between the skin and the constricting fiber, cut the fiber against the probe with fine-tipped scissors or a scalpel, then unwind and remove all of the remaining material. Management of Hair-Thread Tourniquet Syndrome – PEMBlog.pdf Another described option is a cutting suture needle. Pass the curve of the needle beneath the constricting fiber, then lift and use a gentle sawing motion to divide the band. Management of Hair-Thread Tourniquet Syndrome – PEMBlog.pdf Regardless of which mechanical technique you use, be careful about declaring victory after removing one piece of hair. There may be multiple strands, and a deeply embedded portion can remain even after the obvious part has been removed. Now we get to the more difficult situation. The fiber is deeply embedded, you can’t completely visualize it, there’s significant tissue injury or severe edema, or you’ve attempted another removal technique and the appendage still isn’t adequately reperfusing. At that point, you need to definitively release the constriction. Management of Hair-Thread Tourniquet Syndrome – PEMBlog.pdf Before we talk about that technique, let’s talk about anesthesia. For a digital or ring block, plain lidocaine is a reasonable default. There’s good contemporary evidence that lidocaine with epinephrine can be safely used in healthy, well-perfused digits, so this isn’t about going back to the old teaching that epinephrine can never be used in a finger. The problem is that those studies don’t specifically address the situation we have here: an appendage whose perfusion may already be compromised by a constricting tourniquet. And there’s another practical consideration. Return of perfusion is one of the things we’re going to use to determine whether our procedure actually worked. So in a

  3. Oct 19

    Toxicology: Calcium Channel Blockers

    Calcium channel blocker ingestions can cause profound bradycardia, hypotension, conduction abnormalities, and shock, and even a single tablet can be dangerous in a young child. In this episode of PEM Currents, we review the recognition and management of pediatric calcium channel blocker toxicity, including differences between dihydropyridine and non-dihydropyridine agents, high-dose insulin therapy, calcium and vasopressor support, and when to consider VA-ECMO. Learning Objectives After listening to this episode, learners should be able to: Recognize the clinical manifestations of calcium channel blocker toxicity and distinguish the typical effects of dihydropyridine and non-dihydropyridine agents. Describe the initial evaluation and management of a child with suspected calcium channel blocker toxicity, including the roles of calcium, atropine, high-dose insulin therapy, and vasopressors. Identify children who require prolonged observation, ICU admission, or escalation to advanced therapies such as VA-ECMO. References Management of calcium channel blocker toxicity in the pediatric patient. J Pediatr Pharmacol Ther. 2019;24(5):378-386. Are one or two dangerous? Calcium channel blocker exposure in toddlers. J Emerg Med. 2007. Intravenous lipid emulsion treatment for calcium-channel blocker intoxication: pediatric case series and review of the literature. Pediatr Emerg Care. 2022. Audette M, Comstock G. Is beta blocker toxicity associated with hypoglycemia? J Med Toxicol. 2026;22(3):357-363. doi:10.1007/s13181-026-01134-8. Script This is the original script for the episode, written by Drs. Robbie Daulton and Brad Sobolewski 1. Why CCBs Are So Dangerous Calcium channel blockers are an increasingly prescribed drug class which includes amlodipine, verapamil, diltiazem, and nifedipine. Unlike some of the ingestions we cover in this series, there’s no single reliably curative reversal agent. For non-dihydropyridine agents like verapamil and diltiazem especially, a single adult tablet can be lethal to a toddler; that’s exactly why they sit on the “one pill can kill” list. The sleepy, bradycardic toddler with altered mental status can look like sepsis or a metabolic problem well before it looks like a toxic ingestion, which is why this presentation is a challenge to identify. 2. How Kids Present The presentation depends heavily on which calcium channel blocker we’re talking about. Nausea and vomiting are the most common early complaint across all of these agents, so don’t be reassured by a benign-sounding chief complaint. Dihydropyridines, think amlodipine and nifedipine, are selective for vascular smooth muscle at therapeutic doses, so they mostly cause peripheral vasodilation and reflex tachycardia. But in overdose, that selectivity is lost, meaning you can see cardiogenic or distributive shock. Non-dihydropyridines, verapamil and diltiazem, hit the heart directly, meaning they can cause primarily cardiogenic shock. They slow the sinus node and block AV conduction, leading to sinus bradycardia, first-degree or higher-grade AV block, and sometimes a junctional escape rhythm, with a QRS that usually stays narrow since CCBs spare intraventricular conduction. 3. Pharmacology Pearls Calcium channel blockade doesn’t stop at the heart and vessels. These L-type channels also exist on pancreatic beta cells. Blockade suppresses insulin secretion and worsens peripheral insulin resistance. Cardiac myocytes become relatively starved of a key fuel during this stress state. High-dose exogenous insulin restores myocardial glucose uptake and improves contractility, aiding in cardiogenic shock states. 4. Work Up and Treatment Remember, if you have a child who presents with concerns for a CCB, it is important to urgently contact the Poison Control Center. Start with the fundamentals: ABCs, IV or IO access, glucose check, and a bedside EKG looking for that bradycardia and AV block. If the child is in shock, get a bedside echo early. Distinguishing cardiogenic from a distributive picture changes your resuscitation, and it’s a particularly important step for dihydropyridine overdoses where peripheral vasodilation, not pump failure, may be driving the hypotension. Send a blood gas with lactate (this will help distinguish from DKA), a basic metabolic panel, and an ionized calcium. A chest X-ray is worth getting if there’s evidence of severe toxicity or pulmonary edema, and an abdominal X-ray can help if you’re worried about a pill bezoar, especially with sustained-release products. For decontamination, activated charcoal can be considered if you’re early and the airway is protected. You can consider whole bowel irrigation, especially when faced with sustained-release products or when tablets are radiographically visible. For the shock itself, start with fluids and IV calcium repletion as a temporizing bridge. Atropine may be required for symptomatic bradycardia. The cornerstone for inotropic support needed in cardiogenic shock is high-dose insulin therapy: a bolus of 1 U/kg of regular insulin, followed by an infusion, paired with dextrose and glucose monitoring. Insulin can cause hypoglycemia, hypokalemia, and an increased volume/solute load, meaning frequent lab and volume status monitoring is important. For refractory cases, the Poison Center may recommend norepinephrine, or methylene blue, hydroxocobalamin, and angiotensin II. Glucagon appears in older references, but the evidence behind it is thin and inconsistent. Consider VA-ECMO for refractory cardiogenic shock or cardiac arrest despite maximal medical therapy. If you need to intubate, avoid benzodiazepines and barbiturates since they’ll exacerbate the hypotension. Pre-treat anticipated bradycardia with atropine and favor rocuronium over succinylcholine. 5. Who Goes Home, Who Gets Admitted Disposition hinges on the agent and the formulation. Any reported ingestion of a non-dihydropyridine, verapamil or diltiazem, in a toddler warrants an ED visit. Asymptomatic children after a confirmed immediate-release ingestion still need at least six hours of monitoring. Any exposure to a sustained-release or extended-release product requires longer observation, up to twenty-four hours. Anyone symptomatic, hemodynamically unstable, or on calcium, insulin, or vasopressor support needs an ICU bed. 6. Three Take-Homes Think calcium channel blocker whenever you see bradycardia, hypotension, +/- hyperglycemia. A single non-dihydropyridine tablet in a toddler is a genuine “one pill can kill.” It deserves an ED evaluation and a call to the Poison Center. Fluids and calcium buy you time, but early high-dose insulin euglycemic therapy is your cornerstone treatment for refractory cardiogenic shock. Vasopressors should be considered a helpful adjunct, with VA-ECMO kept in reserve for refractory shock or arrest.

  4. Oct 12

    Toxicology: Iron

    Iron poisoning can be deceptive. Early symptoms can look like routine gastroenteritis, children may appear to improve during a latent phase, and significant toxicity can progress to metabolic acidosis, shock, and hepatic injury. In this episode of PEM Currents, we review the recognition and management of pediatric iron toxicity, including when to obtain a serum iron level, the role of abdominal radiographs and whole bowel irrigation, indications for deferoxamine, and disposition. Learning Objectives After listening to this episode, learners should be able to: Recognize the clinical stages of pediatric iron toxicity and identify features concerning for significant systemic toxicity. Use the estimated elemental iron dose, serum iron concentration, and abdominal radiography to evaluate a child with a suspected iron ingestion. Describe the emergency management of iron toxicity, including supportive care, whole bowel irrigation, indications for deferoxamine, and appropriate disposition. References Manoguerra AS, Erdman AR, Booze LL, et al. Iron ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2005;43(6):553-570. Halil H, Tuygun N, Polat E, Karacan CD. Minimum ingested iron cut-off triggering serious iron toxicity in children. Pediatr Int. 2019;61(5):444-448. Klein-Schwartz W, Oderda GM, Gorman RL, Favin F, Rose SR. Assessment of management guidelines: acute iron ingestion. Clin Pediatr (Phila). 1990;29(6):316-321. Banner W Jr, Tong TG. Iron poisoning. Pediatr Clin North Am. 1986;33(2):393-409. Script This is the original script for the episode, written by Drs. Robbie Daulton and Brad Sobolewski 1. Why Iron Matters Iron is one of the most dangerous toxic ingestions we see in young children. It’s found in prenatal vitamin and iron supplements, and the small, often candy-like tablets make exploratory toddler ingestions particularly concerning. Historically, iron was a leading cause of death from unintentional pediatric drug ingestion. What makes iron especially important in the ED is that early toxicity can look just like gastroenteritis, with vomiting, diarrhea, and abdominal pain. If you’re not thinking about an ingestion, it can be easy to miss. 2. How Kids Present: The Five Stages Iron follows a staged, sometimes deceptive, clinical course, although not every child progresses through every stage. Stage one begins 30 minutes to six hours after ingestion with vomiting, diarrhea, abdominal pain, and sometimes GI bleeding from direct mucosal injury. This is the stage that can easily be mistaken for gastroenteritis. Stage two, from about six to 24 hours, is the trap. GI symptoms may improve and the child may appear better, even as systemic toxicity progresses. Stage three, typically 12 to 24 hours after ingestion, is characterized by shock and metabolic acidosis. Children may be hypotensive, tachycardic, lethargic, and poorly perfused. Stages four and five occur later. Hepatic failure can develop over the next several days, while GI strictures and obstruction can occur weeks later. The pattern to remember is early GI symptoms, apparent improvement, and then unexplained shock and metabolic acidosis. That should make you think about iron toxicity even if the ingestion wasn’t clear from the history. 3. Pharmacology Pearls Iron causes toxicity in two ways. First it directly injuries the GI mucosa, causing the early vomiting, diarrhea, abdominal pain. Once absorbed, free iron overwhelms the body’s binding capacity (specifically ferritin and transferrin) and causes cellular and mitochondrial injury, contributing to metabolic acidosis, vasodilation, and shock. Serum iron typically peaks two to six hours post-ingestion, which is why the serum iron concentration should be measured four to six hours after ingestion. With enteric-coated or extended-release preparations, absorption can be delayed, so a repeat level may be necessary. 4. Working It Up and Treating It Start with the basics: ABCs, early IV or IO access, and aggressive treatment of shock. These children may need significant fluid resuscitation and vasoactive support. The most useful diagnostic test is a serum iron level drawn four to six hours after ingestion. Under 350 micrograms per deciliter is associated with minimal toxicity, 350 to 500 with mild to moderate toxicity, above 500 with serious systemic toxicity, and above 1,000 with severe toxicity and increased risk of mortality. But treatment decisions should be based on the entire clinical picture, not just the iron level. Check electrolytes, an anion gap, blood gas, lactate, liver enzymes, and coagulation studies to assess the severity of systemic toxicity. An abdominal X-ray can be helpful because many iron tablets are radiopaque. A positive film confirms tablets are present and can help guide decontamination, but a negative X-ray does not exclude an iron ingestion. Like all other periodic table elements, activated charcoal does not bind iron. If tablets are visible on imaging, whole bowel irrigation should be considered. For serious toxicity, including shock, metabolic acidosis, altered mental status, or a serum iron level above 500, consider IV deferoxamine. Hypotension can occur with rapid administration, so make sure the child has adequate volume resuscitation. Most importantly, treat the patient, not the iron level. Aggressively resuscitate shock, reassess frequently, and involve Poison Control early for any child with significant symptoms or a potentially toxic ingestion. 5. Who Goes Home, Who Gets Admitted For disposition, start with the estimated elemental iron dose, not the total tablet or iron salt weight. Less than 20 milligrams per kilogram is generally low risk, while 40 milligrams per kilogram or more should raise concern for significant toxicity. Newer pediatric data suggest serious toxicity may occur at lower doses, but the reported dose is imperfect, so symptoms and the serum iron concentration matter more than any single cutoff. Pay attention to what was actually ingested. Prenatal vitamins often contain substantial amounts of elemental iron, commonly around 27 to 65 milligrams per tablet, while multivitamins often contain little or no iron. A toddler can therefore reach a toxic dose with only a handful of prenatal vitamins. An asymptomatic child more than six hours after a low-risk ingestion with a reassuring serum iron level can typically go home. Children with significant symptoms or ongoing fluid requirements should be admitted. Hemodynamic instability or the need for deferoxamine warrants ICU-level care. Discuss significant ingestions with Poison Control. After significant toxicity, counsel families that GI strictures can develop weeks later and present with recurrent vomiting or obstruction. 6. Three Take-Homes Iron poisoning is deceptive. Early vomiting and diarrhea can look like gastroenteritis, and apparent improvement during the latent phase does not mean the child is in the clear. Obtain a serum iron level four to six hours post-ingestion. It’s your most useful test, but interpret it alongside the clinical picture. Activated charcoal does not bind iron. Consider whole bowel irrigation when tablets are visible on imaging, and treat serious toxicity, including shock, metabolic acidosis, altered mental status, or an iron level above 500, with aggressive supportive care and deferoxamine.

  5. Aug 26

    Saline or Balanced Fluids? What PRoMPT BOLUS Means for Pediatric Sepsis

    In children with septic shock, does the choice between balanced crystalloids and 0.9% saline actually matter? This episode reviews the composition and physiologic differences between commonly used crystalloids, summarizes the 2026 PRoMPT BOLUS trial, and discusses how its findings fit with the updated Surviving Sepsis Campaign pediatric guidelines. We also consider the trial’s limitations and what the results mean for fluid selection at the bedside. Learning Objectives By the end of this episode, listeners should be able to: Compare the composition and physiologic effects of 0.9% saline and balanced crystalloids used for pediatric fluid resuscitation. Summarize the design and major findings of the PRoMPT BOLUS trial. Describe important limitations of PRoMPT BOLUS when applying its results to children with septic shock. Apply current evidence and 2026 Surviving Sepsis Campaign recommendations when selecting crystalloid fluids for pediatric septic shock. References Weiss SL, Peters MJ, Oczkowski SJW, et al. Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026. Pediatr Crit Care Med. 2026. Published April 1, 2026. Jointly issued by the Society of Critical Care Medicine and Infectious Diseases Society of America. Recommendation 24 suggests balanced/buffered crystalloids over 0.9% saline for children with septic shock requiring fluid boluses (conditional recommendation, very low certainty), while recognizing 0.9% saline as a suitable alternative and preferred in selected situations such as hyponatremia or concern for increased intracranial pressure. Balamuth F, Weiss SL, Long E, et al. Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock. N Engl J Med. 2026. Published April 24, 2026. PRoMPT BOLUS was a large pragmatic randomized trial comparing balanced crystalloids with 0.9% saline in children treated for suspected septic shock and found no reduction in major adverse kidney events within 30 days with balanced fluids. Transcript This transcript was generated using Descript and subsequently reviewed and lightly edited for spelling, grammar, and clarity. Minor inaccuracies may remain, and the audio recording should be considered the definitive version of this content. Welcome to PEM Currents: The Pediatric Emergency Medicine Podcast. As always, I’m your host, Brad Sobolewski, and today we’re gonna talk about which fluid we should use when managing a septic pediatric patient. So when we resuscitate a child with septic shock, the major decision is usually not whether to give crystalloid, but which crystalloid to give. And for a long time, there’s been a gradual shift towards balanced fluids such as Lactated Ringer’s or Plasma-Lyte, largely because they are more physiologic and produce less hyperchloremia than normal saline. The question’s always been whether those biochemical differences actually translate into better clinical outcomes. That is the question that a study called PRoMPT BOLUS was designed to answer. So before getting into the trial, it’s worth briefly reviewing what these fluids actually contain. So normal saline is 0.9% sodium chloride. It contains one hundred and fifty-four milliequivalents per liter of sodium and a hundred and fifty-four milliequivalents per liter of chloride. The chloride concentration is substantially higher than plasma. Balanced crystalloids contain less chloride and have some other electrolytes and a buffer. Lactated Ringer’s contains approximately a hundred and thirty milliequivalents per liter of sodium, one hundred and nine of chloride, four of potassium, a small amount of calcium, and lactate as a buffer. Plasma-Lyte contains approximately one hundred and forty of sodium, ninety-eight of chloride, five of potassium, magnesium, and acetate and gluconate as buffers. The concern with normal saline is that the large chloride loads can produce hyperchloremic metabolic acidosis. There’s also been concern about adverse effects on renal blood flow and kidney function. Balanced fluids are designed to more closely approximate plasma composition, so the hypothesis has been that they might reduce kidney injury. That hypothesis has been supported by physiologic data and by some adult studies, although pediatric evidence before PRoMPT BOLUS was limited and inconsistent. The 2026 Surviving Sepsis Campaign Pediatric Guidelines recommend crystalloids over albumin for initial resuscitation and conditionally suggest balanced or buffered crystalloids over 0.9% saline in children with septic shock who require fluid boluses. Importantly, that recommendation is based on very low-certainty evidence. Balanced options again include Lactated Ringer’s, Hartmann’s solution, or Plasma-Lyte. If balanced fluids are not readily available, saline remains an acceptable alternative. Saline may also be preferable in some specific situations like significant hyponatremia or concern for increased intracranial pressure. For children in resource-abundant settings, the general approach is still ten to twenty mLs per kilo per bolus with reassessment after each bolus, potentially up to forty to sixty mLs per kilo in the first hour if perfusion remains abnormal and there are no signs of fluid overload. Now, PRoMPT BOLUS, the full name of which is the Pragmatic Pediatric Trial of Balanced versus Normal Saline Fluid in Sepsis, was an international randomized pragmatic trial designed to specifically compare the two fluid strategies in children with suspected septic shock. The final trial enrolled nine thousand and forty-one children from two months to younger than eighteen years across forty-seven emergency departments in five countries. Children were randomized to predominantly balanced crystalloid or predominantly 0.9% saline, and the assigned fluid strategy was used for bolus and maintenance crystalloid during the initial treatment period. The balanced fluid arm was not a single product. Depending on the site, children could get Lactated Ringer’s, Hartmann’s solution, or Plasma-Lyte. That’s important when interpreting the study. PRoMPT BOLUS was really testing a strategy of predominantly balanced crystalloid versus a strategy of predominantly saline use rather than comparing LR versus saline alone, though LR was the most commonly used one. The primary outcome was something called MAKE30, M-A-K-E thirty, or major adverse kidney events within thirty days. This was a composite outcome that included death, new renal replacement therapy, or persistent kidney dysfunction. That choice of outcome is useful because the biologic rationale for balanced fluids has always centered largely on kidney protection. The investigators were therefore asking whether the lower chloride exposure associated with balanced fluids translated into clinically meaningful renal benefit. So what was the result? Well, the spoiler is that the answer was no. So MAKE30 occurred in three point four percent of children receiving balanced fluids and three percent receiving saline. The relative risk was one point one with a ninety-five percent confidence interval from point eight eight to one point four. There were also no significant differences in death, new renal replacement therapy, persistent kidney dysfunction, or hospital-free days. In practical terms, balanced crystalloids did not improve the major patient-centered outcomes the trial was designed to measure. There were clear biochemical differences between the groups. Hyperchloremia occurred in thirty-one point four percent of children receiving balanced fluids compared with forty-nine percent with saline. Hypernatremia was also less common with balanced fluids, one point eight versus three point one percent. Hyperlactatemia was slightly more common in the balanced fluid group, nineteen point eight compared with sixteen point seven percent. So the fluids behaved differently in the ways that you would expect physiologically. Balanced crystalloids clearly reduced hyperchloremia, but that difference did not translate into fewer major kidney events, less dialysis, shorter hospitalization, or lower mortality. There are several limitations to this study worth keeping in mind. The first is that this was a broad emergency department population with suspected septic shock, not a study limited to children with the most severe forms of shock. Only a minority of patients required vasoactive medications, and overall mortality was low. The results are therefore most applicable to the typical child with suspected septic shock receiving early ED resuscitation. They do not completely answer whether fluid composition might matter more in a smaller subgroup of children receiving very large fluid volumes or prolonged resuscitation. The second limitation is that the event rate for MAKE30 was lower than expected. When the trial was designed, investigators anticipated an event rate of about six percent in the saline group. The observed rate was closer to three percent. That means there were fewer outcome events than anticipated, which reduced the ability to detect a very small treatment effect. So the trial makes a large benefit from balanced fluids unlikely, but it can’t exclude a small or subtle difference. A third limitation is that the balanced fluid group included several different solutions. Lactated Ringer’s, Plasma-Lyte, and Hartmann’s are all considered under the umbrella of balanced crystalloids, but they’re not chemically identical. The study therefore supports the broader conclusion that a balanced fluid strategy is not superior to saline for most children in this setting, rather than providing equivalence between any single specific balanced solution and saline, even though Lactated Ringer’s is used far and away most often. The trial was also intentionally pragmatic, which means that there was some crossover between fluid types. Adherence was defined as receiving at least s

  6. Aug 5

    Minor Procedures: Embedded Earrings

    Embedded earrings are a common pediatric emergency department presentation that can usually be managed quickly and safely without procedural sedation. This episode reviews why earrings become embedded, how to distinguish uncomplicated earlobe cases from higher-risk cartilage piercings, step-by-step removal techniques, pain control strategies, and appropriate wound care, antibiotics, and follow-up. Learning Objectives Recognize the evaluation and management of embedded earlobe earrings, including indications for local anesthesia, incision, and removal techniques. Differentiate uncomplicated earlobe piercings from cartilage piercings that require additional concern for perichondritis, Pseudomonas infection, and possible ENT consultation. Apply evidence-based post-procedure care, including appropriate wound management, antibiotic selection, and counseling to help prevent future embedded earrings. References Timm N, Iyer S. Embedded earrings in children. Pediatr Emerg Care. 2008;24(1):21-24. Muntz HR, Pa-C DJ, Asher BF. Embedded earrings: a complication of the ear-piercing gun. Int J Pediatr Otorhinolaryngol. 1990;19(1):73-76. Kim MM, Goldman RD. Ear-piercing complications in children and adolescents. Can Fam Physician. 2022;68(9):661-663. Transcript This transcript was generated using Descript and subsequently reviewed and lightly edited for spelling, grammar, and clarity. Minor inaccuracies may remain, and the audio recording should be considered the definitive version of this content. Welcome to PEM Currents: The Pediatric Emergency Medicine Podcast. As always, I’m your host, Brad Sobolewski. Today, we’re continuing our new series on minor procedures. These are the procedures we perform all the time in pediatric emergency departments. They’re not the subject of giant multicenter trials or big keynote lectures, but they are the procedures that families remember. If you make them quick, comfortable, and maybe even a little less scary, families and patients will remember that. And if the procedure turns into a wrestling match with three people trying to hold down a screaming child while you’re searching for an earring backing, they’re gonna remember that too. Today’s topic is embedded earrings. A kid walks into the emergency department holding one ear. The earlobe is swollen and red, and the parent says, “I can’t find their earring.” It didn’t disappear. The ear basically swallowed it, and the parents almost always feel bad. They think they did something wrong or they waited too long. Honestly, this happens all the time. The first one can be a little intimidating because the hardware isn’t always where you expect it to be, but after you’ve removed a few of these, you’ll realize they’re actually pretty straightforward. Most can be managed right in the emergency department or a well-resourced urgent care. One of the best studies on the topic actually came from Cincinnati Children’s. Tim and Iyer reviewed over 100 children who presented to our emergency department with embedded earrings over about a four-and-a-half-year period. The median age was eight years, and about 60% of the children were younger than 10. That fits with most of our clinical experience. Younger children are more likely to sleep on new piercings, play with their earrings, forget the aftercare instructions, or simply not notice that the backing has become too tight. Nearly 90% of embedded earrings involve the earlobe rather than the cartilage, and in about two-thirds of patients, it wasn’t the decorative front of the earring that got stuck, it was the posterior backing or clasp. That’s helpful because I, um, almost always start looking on the back of the ear, ‘cause usually they’ve taken off the front. About one-third of children had evidence of a localized infection when they presented. Usually, that meant tenderness, erythema, swelling, and maybe a little purulent drainage or crusting around the piercing. Doesn’t necessarily mean they need oral or systemic antibiotics, but it does mean they shouldn’t wait another week hoping the earring somehow works itself out. So why does this happen? It’s really a pressure injury. The backing gets tightened against the earlobe, either because it was applied too snugly when the ears were pierced or because the ear swells afterward and suddenly there’s no room for the tissue to expand. That constant pressure decreases blood flow, produces local inflammation, and eventually the skin begins to grow around the earring hardware. Kids speed the whole process along by twisting the earrings, playing with them, sleeping on them, bumping them during play, and not cleaning the piercing consistently while it’s healing. One thing that probably contributes as well is the spring-loaded ear piercing gun. These devices place the earring and immediately snap on the backing, and sometimes that backing ends up much tighter than it should be. If swelling develops over the next day or so, the backing can quickly become buried beneath the skin. It’s one of the reasons I generally recommend families avoid piercing guns and instead use a method that leaves just a little room for post-procedure swelling. When these patients show up in the emergency department, they almost always complain of pain, swelling, redness, and tenderness around the piercing site. Sometimes there’s drainage. Sometimes the parent says they can’t unscrew the backing anymore. Sometimes they tell you they can feel the earring in the earlobe, but you can’t actually see it. Now, I’ll get to the procedure technique in just a minute. But before I start talking about that, I do wanna separate earlobe piercings from cartilage piercing, ‘cause they’re really different problems. Once cartilage is involved, the stakes go up considerably. Cartilage has relatively poor blood supply, making it much more susceptible to perichondritis, chondritis, cartilage necrosis, and permanent cosmetic deformity. The bacteria may be different as well. We’ll come back to that later. For now, though, let’s stay with the earlobe because, frankly, that’s where almost all of these procedures occur. All right. Before you start any procedure, you wanna have everything ready. So I’ll have local anesthetic, so lidocaine or lidocaine with epi. Epi is totally fine in the earlobe. At least two mosquito hemostats, stuff to grab the earring, an 11 blade, gauze, saline, and a good light source. I think if there’s any chance I’ll need to make a small incision, I’ll prep the ear before I do anything with, uh, betadine or chlorhexidine. Once the ear starts bleeding a little or the child starts moving around, everything gets just a little harder to see and grab. Absolutely bring your child life specialist if you’ve got them and someone to hold, like a medic or a PCA. One of the interesting things about the Cincinnati study is that none of the 100 children required procedural sedation. None. And honestly, that fits with my experience. The overwhelming majority of these can be managed with local anesthesia alone. For the earlobe, I usually perform a small field block using one percent lidocaine with epinephrine, using a twenty-seven or thirty-gauge needle. Epi is perfectly safe in the earlobe and gives you a little hemostasis while you’re working. One thing I probably do differently from some people is I actually wait for the anesthetic to work a little longer. I don’t just block and immediately start. I’ll wait at least five minutes. Honestly, it’s usually closer to seven to ten minutes. During that time, I’m talking with the family, keeping child life involved, making sure all my equipment is ready, and just letting everybody settle down a bit. Those extra few minutes make the whole procedure a lot easier. And again, this is pediatrics, so never underestimate distraction. You’ve got videos, music, you know, stuffed animal, a toy. Parents should be there holding the child’s hand. You gotta coach the parents as well. And sometimes that’s really all you need, a good block and some distraction. Of course, some kids do need more. For an anxious child, you can use intranasal midazolam or oral midazolam. If your department has nitrous oxide, this is a great procedure for it because it’s usually pretty quick. You’re often treating anxiety more than pain. I have used ketamine a handful of times, and not because something went wrong, but just because you have an extremely anxious child, and you’re not gonna accomplish the procedure safely any other way. First, figure out what you can see and what you can feel. Sometimes both the decorative front and backing are still visible, but the ear is simply too swollen to separate them normally. Those are the easy ones. I’d grab each side with a mosquito hemostat, disengage the backing from the post, and remove the earring. More commonly, the backing is buried beneath the skin. The decorative front may still be attached, or the parents may have already removed it and left the backing sitting in the earlobe. I’ll gently compress the earlobe from the front while looking at the back. That pressure tents the skin enough to expose a few millimeters of metal through the original piercing hole, and that may be all that I need to grab the backing and remove it. If you still can’t see it, keep palpating. Usually, I can feel the hardware through the swollen tissue. Once you localize it, I’ll make a tiny incision on the back of the earlobe directly over it. And when I say tiny, I mean tiny, like a couple millimeters, just enough to expose the metal. But don’t be afraid of making that incision. It’s honestly usually the difference between wrestling with the earring for ten minutes and having it out within sixty seconds. From there, the rest is pretty straightforward. Whether the front is buried, the backing is buried, or neither side is visible, I gen

  7. Jul 20

    Cyclospora

    Cyclospora is an uncommon but important cause of prolonged watery diarrhea in children, particularly during the summer months and during foodborne outbreaks. This episode reviews the epidemiology, clinical presentation, diagnostic pitfalls, treatment, and practical emergency department approach to recognizing and managing pediatric cyclosporiasis.   Learning Objectives Recognize the clinical features and epidemiology of Cyclospora cayetanensis infection in children, including when to suspect the diagnosis in patients with prolonged watery diarrhea. Select appropriate diagnostic testing for cyclosporiasis and identify the limitations of routine stool cultures, ova and parasite examinations, and gastrointestinal pathogen panels. Apply evidence-based treatment and supportive care for pediatric cyclospora infection, including appropriate antimicrobial therapy, hydration, and follow-up considerations. References Stobbe M. Outbreak of diarrhea-causing parasite grows to more than 1,000 cases. ABC News. Published July 8, 2026. Accessed July 10, 2026.   Bilung LM, Tahar AS, Yunos NE, et al. Detection of Cryptosporidium and Cyclospora oocysts from environmental water for drinking and recreational activities in Sarawak, Malaysia. Biomed Res Int. 2017;2017:4636420. doi:10.1155/2017/4636420.   Giangaspero A, Gasser RB. Human cyclosporiasis. Lancet Infect Dis. 2019;19(7):e226-e236. doi:10.1016/S1473-3099(18)30789-8.   Pyzocha N, Cuda A. Common intestinal parasites. Am Fam Physician. 2023;108(5):487-493.   Centers for Disease Control and Prevention. Clinical care of cyclosporiasis. Updated March 8, 2024. Accessed July 10, 2026.  Transcript This transcript was generated using Descript and subsequently reviewed and lightly edited for spelling, grammar, and clarity. Minor inaccuracies may remain, and the audio recording should be considered the definitive version of this content.   Welcome to PEM Currents: The Pediatric Emergency Medicine Podcast. As always, I’m your host, Brad Sobolewski. It’s July and a seven-year-old comes into your emergency department with 10 days of watery diarrhea. They were seen earlier in the week and told it was probably viral gastroenteritis. Maybe they got a prescription for ondansetron, maybe they didn’t. Stool cultures have already come back negative. Mom tells you, “Every time I think he’s finally getting better, the explosive diarrhea comes right back.” So what’s going on? Today we’re talking about Cyclospora. Honestly, it’s one of those organisms that most of us forget about until summer rolls around, or since medical school. We don’t diagnose it every week, and depending on where you practice, you may go years without seeing a case. But then an outbreak happens, and maybe just a handful of sporadic cases show up, and suddenly you’re reminded that not every child with prolonged diarrhea has viral gastroenteritis. Cyclospora cayetanensis is a coccidian protozoan that’s transmitted through contaminated food or water. In the United States, it’s most commonly associated with imported fresh produce, things like cilantro, basil, lettuce, salad mixes, and berries. Unlike bacterial food poisoning, everyone at the picnic usually isn’t sick, so it often presents as an isolated illness because the exposure happened days earlier and may have involved only one particular food item. Families are often trying to remember the one thing that they ate that made everybody sick. Honestly, sometimes it’s simply the salad they bought at the grocery store a week ago. One thing that’s helped me remember these organisms over the years is that they each sort of develop their own personality. You know, it’s often confused with Giardia and Cryptosporidium. So if the diarrhea is greasy, think Giardia. If it’s profuse, watery diarrhea after swimming, think Cryptosporidium. If it’s prolonged, watery diarrhea during the summer, think Cyclospora. Now, obviously there are exceptions, but I think that’s a pretty useful framework, especially when you’re seeing patients one after another in a busy ED. One of my favorite pearls about Cyclospora, and I think it’s probably the one fact that’s most worth remembering because it explains how it sort of works. Unlike Giardia or Cryptosporidium, the oocysts that are passed in stool aren’t immediately infectious. They actually have to spend days to weeks out in the environment before they mature enough to infect somebody else. So Cyclospora isn’t really spread by the kids sitting next to them at daycare. It’s spread by the salad they both ate last week. I think that’s a lot easier to remember than trying to memorize the organism’s life cycle. The incubation period averages about seven to 10 days, so by the time symptoms begin, families usually don’t remember exactly what their kid ate. They’re certainly not connecting today’s diarrhea with the salad they had a week ago. The diarrhea itself is usually watery, sometimes pretty high volume, sometimes even explosive. One thing that’s a little deceptive is that it tends to wax and wane. Parents will tell you, “Yesterday I thought we had finally turned the corner,” and today they’re right back where they started. Along with the diarrhea, you’ll often see abdominal cramping, bloating, nausea, fatigue, maybe even a low-grade fever, and if this has been going on for a while, some weight loss or poor weight gain. Most of these kids don’t walk in looking critically ill. They walk in because they’re still having diarrhea when everyone expected them to be over it. That’s really the patient where Cyclospora should come to mind. And of course, not every child with prolonged diarrhea has it. Giardia is still incredibly common, especially after untreated water exposure, camping, or daycare. Again, those kids have greasy, foul-smelling stools with bloating and flatulence. Cryptosporidium is the swimming pool organism. Those oocysts are remarkably resistant to chlorine, so swimming pools, splash pads, and water parks should all get your attention. Those patients usually have profuse watery diarrhea, but in otherwise healthy children, it tends to run its course over a couple weeks. Cyclospora is different because it just hangs around. That’s really what makes me think about it. It’s not necessarily how sick the kid is, it’s that they’re still sick when they should actually be getting better. So aside from when you’re in the middle of an outbreak, when should you actually suspect it? It’s really when a few things start lining up. The diarrhea has lasted more than a week. Maybe it got a little better and then came back. The kid has lost some weight or looks a little dehydrated. It’s summertime. The bacterial stool studies are negative. Maybe there’s a history of travel. Maybe there isn’t. Maybe there’s a history of eating fresh produce. Maybe there isn’t. At some point, you have to stop saying, “Eh, it’s probably still viral,” and start asking yourself whether you’re dealing with something else. One teaching point that’s worth repeating, partly because it shows up on board exams and partly because it explains the epidemiology, is that Cyclospora isn’t spread directly from person to person. Fresh stool isn’t immediately infectious because those oocysts still have to sporulate in the environment before they can infect the next person. So let’s say you’re thinking about Cyclospora. What do you actually order? A routine stool culture isn’t gonna help you. Even a routine ova and parasite examination may not be enough. That’s an easy mistake to make because a lot of us were taught persistent diarrhea, send culture and O&P or a stool molecular pathogen panel. Many labs don’t specifically look for Cyclospora unless you ask them to or order it specifically. So there’s gastrointestinal PCRs for it, but you have to order them separately. So you can actually get back a negative O&P and feel reassured when in reality no one’s really tested for Cyclospora. If your hospital has a multiplex GI PCR panel that includes it, that’s probably what you should order first. If you don’t, you probably have to order it separately. Another board pearl. So if you’re taking a board exam and they describe a child with prolonged watery diarrhea during the summer, maybe after eating fresh produce, and then they casually mention that the routine ova and parasite examination was negative, don’t let that throw you off. That’s actually the clue. The organism may still be there, the lab just wasn’t sent to look for it. If your lab is using microscopy, Cyclospora can be identified with a modified acid-fast stain. The oocysts are a little larger than Cryptosporidium, and one interesting feature is that they stain variably. Some stain bright red, while others hardly stain at all, giving them that classic ghost organism appearance, which I think is just, like, cool. And because oocyst shedding is intermittent, collecting two or three stool specimens over several days can improve the diagnostic yield if you still have a high index of suspicion. The good news is that once you make the diagnosis, treatment is actually pretty straightforward. Trimethoprim-sulfamethoxazole remains the treatment of choice. In adult-sized patients, that means trimethoprim one hundred and sixty milligrams plus sulfamethoxazole eight hundred milligrams, just one double-strength tablet, orally twice a day for seven to ten days. For kids greater than two months of age to eighteen years, it’s eight to ten milligrams per kilogram trimethoprim and forty to fifty milligrams per kilogram sulfamethoxazole per day orally in two divided doses for seven to ten days. Most children begin feeling noticeably better within twenty-four to forty-eight hours. Honestly, this can be a pretty satisfying infection to treat because families have often been sea

  8. Jun 4

    Minor Procedures: Fishhook Removal

    Fishhook injuries are common, surprisingly nuanced, and honestly a little intimidating until you’ve removed a few. In this first episode of our Minor Procedures series, we’ll reel in the essentials of pediatric fishhook removal, helping you take the bait on four classic removal techniques, procedural planning, anesthesia strategies, and post-removal management. We’ll discuss when to pull back, when to advance, when not to get hooked on a single technique, and how to avoid turning a simple procedure into the one that got away. Along the way we’ll cover sedation, antibiotics, wound care, and practical pearls to help you land these cases with confidence. Learning Objectives Compare and select among the four major fishhook removal techniques based on hook characteristics, depth of penetration, and anatomic location. Apply evidence-based approaches to analgesia, anxiolysis, procedural sedation, and post-removal management for pediatric fishhook injuries. Identify situations requiring escalation of care, including ocular involvement, contaminated water exposure, tendon or joint involvement, and circumstances where routine management may not be sufficient. References Gammons MG, Jackson E. Fishhook removal. Am Fam Physician. 2001;63(11):2231-2236. Prats M, O'Connell M, Wellock A, Kman NE. Fishhook removal: case reports and a review of the literature. J Emerg Med. 2013;44(6):e375-e380. doi:10.1016/j.jemermed.2012.11.058 Doser C, Cooper WL, Ediger WM, et al. Fishhook injuries: a prospective evaluation. Am J Emerg Med. 1991;9(5):413-415. doi:10.1016/0735-6757(91)90204-w Transcript This episode used an AI-generated transcript created in Descript as an initial draft. The transcript was subsequently edited, expanded, and refined by the author with assistance from OpenAI’s ChatGPT (GPT-5.5). Final editorial decisions and content responsibility remain with the author. Welcome to PEM Currents: The Pediatric Emergency Medicine Podcast. As always, I'm your host, Brad Sobolewski, and today we're gonna start a new series on minor procedures. These are the types of procedures that we perform all the time in the emergency department. They're not the subject of multicenter trials or big keynote lectures, but these are the things that patients and families remember, and trust me, they will remember them whether you do them well or not. First up, fishhook removal. So I'm hoping to reel in some listeners with this one, and so hopefully you'll take the bait, and by the end of this episode you'll understand exactly what angle I'm coming from. And hopefully I'm just not trying to make a bass of myself. So anyway, fishhook removal sounds really simple until you actually start doing it. There's not just one technique. There are four classic approaches, and I'll talk about them all, and which one you choose depends on the hook, whether there's a barb, how deep it is, where it's located, your personal experience with different techniques. Fishhook injuries in children are usually minor and most commonly involve the hands and head, though I've seen them stuck in other body parts as well. Most can be managed in the emergency department or urgent care setting with local anesthesia and basic equipment Of course, if there's concern for tendon involvement, joint penetration, neurovascular compromise, if it's anywhere near the eyeball, you should stop and rethink your plan. You know, so ortho, if it's embedded deeply in a joint, um, anything that involves the eye itself isn't necessarily an emergency department procedure, and I'm not talking about the eyebrow, I'm talking about the globe. Fortunately, that's very rare, but that's definitely an ophthalmology conversation. And so before you even think about removing, you need to understand the hook. Is this a single hook or is this a treble hook? A treble hook is a type of fishing hook that has three individual hooks and barbs arranged in a triangular formation, and they're all fused to a single shank and eye. The eye is where the line gets tied to the hook. Is it freshwater or saltwater? How long has it been there? Is it an old rusty one that was sitting in your garage? Was it underwater for a few hours and then it got hooked in the skin? And honestly, how cooperative is the kid gonna be? Because unlike actual fishing, this is one of the procedures where patience beats blunt force. So the simplest technique is retrograde removal. This is exactly what families think you're gonna do before you walk in the room. You know, just pull it out the way it went in. But that's not how hooks are designed. They have the barb. They're designed to stay in the fish. So most of the hooks that I've removed are barbed hooks, and so you can't just back them out. If you try to pull a hook out the way it came in, it's gonna catch and tug on the tissue, it's gonna lead to more pain, bleeding and tissue distortion and not really gonna get you anywhere. So just pulling it out doesn't work, and family probably would have already tried that at home. The technique I end up using most often is advance and cut. And it kind of sounds wrong the first time you explain it to a family because your solution to removing the hook is to continue to advance the hook, but mechanically, this makes the most sense. So you advance the point of the hook through the skin until the barb exits completely, then use either really good trauma shears or heavy wire cutters to cut the hook in between the shank and the barb. If it's in a location where you have, uh, enough room, I like to hold a hemostat real close to the skin, grabbing the hook. Then I cut near the barb, get the pointy part out of the way, remove the hemostats, and then back it through the skin. This is considered the most reliable technique, and in most reviews it's described as being nearly universally successful, even for larger hooks. In children, I think this needs to be the go-to technique because success matters. You just gotta get it done on the, the first attempt. Kids don't tolerate multiple failed attempts very well. Um, obvious downside is that you create a second puncture wound, but in practice, that puncture is usually controlled and much less traumatic than repeated unsuccessful pulling. Depending on where the skin's at, you may actually need to put a little bit of tension or pressure against the skin to get that hook to poke through. Ultimately, this advance and cut method is the one that you should spend the most time learning and teaching to your trainees. The string yank technique is the one that often is seen at summer camps and on YouTube videos. You loop string or heavy suture or even fishing line around the bend of the hook, apply downward pressure to the shank to disengage the barb, and then pull quickly in line with the shaft of the hook. When it works, it yanks it out almost instantly. That's why the YouTube videos are popular. One second there's a fishhook in the finger, and the next there isn't. The advantage is that this can sometimes just be performed without anesthesia and can even be done at home. The disadvantage is obvious if you work with children. This requires cooperation. Younger kids, anxious kids, a treble hook, something that's deeply embedded, like this isn't gonna work all that well, and it's, again, less reliable with bigger and deeply embedded hooks. The last technique is needle cover. This one gets less attention. It seems elegant, but in practice it's actually pretty hard to do, especially in smaller kid parts. You insert an 18-gauge needle alongside the entry tract until the bevel of that needle covers the barb, and then pull both out together The advantage is that you avoid creating a second puncture wound, and you can minimize tissue trauma. The disadvantage is it's really complex technically. Maintaining alignment of both the hook and needle can be tricky because they sort of like roll and move around. And if you want to do this one, it's probably easier for smaller and medium-sized hook rather than larger embedded or treble hooks. And as you might imagine in the literature, there's not really any randomized trials comparing these techniques. Most of what we know comes from prospective observational studies, case series, procedural experience, and expert review. Advance and cut seems to have the broadest success across scenarios. String yank does earn some points for field use and avoiding local numbing. Needle cover is hard to do, but if the parent is absolutely adamant that you don't create a second hole, then that's probably your best option. And as with any procedure, you should probably be facile in multiple techniques in case the first one doesn't work. You don't just want to stand there and flounder. Anyway, most fishhook removals in children can be done with local anesthesia alone. One percent Lido with or without epi is usually enough. Depending on the location, you may need to do a digital block or a field block instead of just injecting directly around the hook because local infiltration itself can distort the anatomy and actually make removal harder. So that's why I like blocking the digit or doing a little bit of a field block around it. If you have time, a topical anesthetic before local infiltration can be a nice gesture. LMX or EMLA can be really helpful, especially for really anxious kids or kids who are escalating before you even start setting up. They take about forty to sixty minutes. About forty-five minutes is probably ideal. So if you can get that put on in triage, that's actually a, a great technique. So if you know you're going to inject to numb to get the fishhook out, and you need a little bit of extra time to get child life or other personnel in the room, by all means, put a topical anesthetic there. It only absorbs into the outer two millimeters, but it'll help with the poke, not necessarily the burning that happens once the lidocaine is in the tissue. And now

4.6
out of 5
94 Ratings

About

PEM Currents: The Pediatric Emergency Medicine Podcast is an evidence-based podcast focused on the care of ill and injured children in the Emergency Department. The host is Brad Sobolewski, MD, MEd author of PEMBlog.com and a Professor of Pediatric Emergency Medicine at Cincinnati Children’s and the University of Cincinnati.

You Might Also Like